Premium
25‐Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy
Author(s) -
Huang JeeFu,
Ko YuMin,
Huang ChungFeng,
Yeh MingLun,
Dai ChiaYen,
Hsieh MengHsuan,
Huang ChingI,
Yang HuaLing,
Wang ShuChi,
Lin ZuYau,
Chen ShinnChern,
Yu MingLung,
Chuang WanLong
Publication year - 2017
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/hepr.12878
Subject(s) - odds ratio , medicine , gastroenterology , confidence interval , hepatitis c virus , vitamin d and neurology , viral load , ribavirin , hepatitis c , immunology , virus
Aim 25‐Hydroxy vitamin D (Vit D) plays a role in treatment outcomes in chronic hepatitis C virus (HCV) infection. We aimed to clarify whether HCV replication is inhibited by Vit D in HCV replicon cells. Clinical implication was assessed for rapid virological response (RVR) and sustained virological response (SVR) among those patients receiving antiviral therapy. Methods Cell survival and viral loads were observed in Con1 (genotype 1b) and J6/JFH (genotype 2a) cells treated with different doses of Vit D. Three groups of patients with different treatment responses were recruited to assess their Vit D levels: group A, RVR−/SVR−; group B, RVR+/SVR−; and group C, RVR+/SVR+. Results The viral load of Con1 cells decreased by 69%, 80%, and 86% following treatment with 1 μM, 5 μM, and 10 μM Vit D, respectively ( P < 0.0001). In J6/JFH cells, it decreased by 12%, 55%, and 80.5% following treatment with 1 μM, 5 μM, and 10 μM Vit D, respectively ( P < 0.0001). There was a significant increase of Vit D between chronic hepatitis C groups, ranging from 4.4 ± 5.6 ng/mL in group A ( n = 44), to 17.2 ± 11.6 ng/mL in group B ( n = 44), and 32.5 ± 37.5 ng/mL of group C ( n = 44) ( P < 0.001). Advanced fibrosis (odds ratio = 0.13, 95% confidence interval = 0.04–0.41, P < 0.001) and Vit D deficiency (<10 ng/mL) (odds ratio = 0.11, 95% confidence interval = 0.03–0.43, P = 0.001) were predictive of SVR in the multivariate regression analysis. Conclusion Vitamin D decreases HCV replication and also contributes to early treatment viral kinetics.